HomeNewsBusinessCompaniesLupin gets tentative US FDA nod for anti-epilepsy drug

Lupin gets tentative US FDA nod for anti-epilepsy drug

Pharma major Lupin’s US subsidiary has got tentative approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Pregabalin Capsules, used for treating pain caused by neurologic diseases and seizures.

July 07, 2011 / 15:37 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol Bureau

Pharma major Lupin

first published: Jul 7, 2011 02:13 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347